Overview
An Introduction to the Mathematical Modeling of Blood Clotting
http://www.ima.umn.edu/2010-2011/SW9.13-15.10/activities/Fogelson-Aaron/ima2010.pdf
Feher, Joseph J. "4.2: Cells, Synapses, and Neurotransmitters." Quantitative Human Physiology: An Introduction. Amsterdam: Elsevier/Academic, 2012. 307-12. Print.
Puri IK, Li L (2010) Mathematical Modeling for the Pathogenesis of Alzheimer’s Disease. PLoS ONE 5(12): e15176. doi:10.1371/journal.pone.0015176
Quantitative common carotid artery blood flow: prediction of internal carotid artery stenosis
http://www.ncbi.nlm.nih.gov/pubmed/294037
"What Is Dementia?" Dementia – Signs, Symptoms, Causes, Tests, Treatment, Care. Alzheimer's Association, n.d. Web. 10 Nov. 2014. <http://www.alz.org/dementia/>.
http://www.ima.umn.edu/2010-2011/SW9.13-15.10/activities/Fogelson-Aaron/ima2010.pdf
Feher, Joseph J. "4.2: Cells, Synapses, and Neurotransmitters." Quantitative Human Physiology: An Introduction. Amsterdam: Elsevier/Academic, 2012. 307-12. Print.
Puri IK, Li L (2010) Mathematical Modeling for the Pathogenesis of Alzheimer’s Disease. PLoS ONE 5(12): e15176. doi:10.1371/journal.pone.0015176
Quantitative common carotid artery blood flow: prediction of internal carotid artery stenosis
http://www.ncbi.nlm.nih.gov/pubmed/294037
"What Is Dementia?" Dementia – Signs, Symptoms, Causes, Tests, Treatment, Care. Alzheimer's Association, n.d. Web. 10 Nov. 2014. <http://www.alz.org/dementia/>.
Pathophysiology
Duyckaerts, Charles, Irene Litvan, Michael J. Aminoff, Francois Boller, and D. F. Swaab. Handbook of Clinical Neurology. Edinburgh: Elsevier, 2008. Print.
Huntington Disease
http://ghr.nlm.nih.gov/condition/huntington-disease
Huntington Disease
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001775/
Imbimbo, Bruno P., PhD, Jay Lombard, DO, and Nunzio Pomara, MD. "Pathophysiology of Alzheimer's Disease." Neuroimaging Clinics of North America 15.4 (2005): 727-53. ScienceDirect. Web. 18 Nov. 2014.
<http://www.sciencedirect.com/science/article/pii/S1052514905001036>.
Kalaria, Raj. "Similarities between Alzheimer's Disease and Vascular Dementia." Journal of the Neurological Sciences 203-204 (2002): 29- 34.ScienceDirect. Web. 18 Nov. 2014.
Parkinson's Disease
http://www.mayoclinic.org/disease-conditions/parkinsons-disease/basics/definition/con-20028488
tau and b-amyloid
Rosen, Howard J., MD, Jeannie Lengenfelder, PhD, and Bruce Miller, MD. "Frontotemporal Dementia." Neurologic Clinics 18.4 (2000): 979-92. ScienceDirect. Web. 17 Nov. 2014.
Huntington Disease
http://ghr.nlm.nih.gov/condition/huntington-disease
Huntington Disease
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001775/
Imbimbo, Bruno P., PhD, Jay Lombard, DO, and Nunzio Pomara, MD. "Pathophysiology of Alzheimer's Disease." Neuroimaging Clinics of North America 15.4 (2005): 727-53. ScienceDirect. Web. 18 Nov. 2014.
<http://www.sciencedirect.com/science/article/pii/S1052514905001036>.
Kalaria, Raj. "Similarities between Alzheimer's Disease and Vascular Dementia." Journal of the Neurological Sciences 203-204 (2002): 29- 34.ScienceDirect. Web. 18 Nov. 2014.
Parkinson's Disease
http://www.mayoclinic.org/disease-conditions/parkinsons-disease/basics/definition/con-20028488
tau and b-amyloid
Rosen, Howard J., MD, Jeannie Lengenfelder, PhD, and Bruce Miller, MD. "Frontotemporal Dementia." Neurologic Clinics 18.4 (2000): 979-92. ScienceDirect. Web. 17 Nov. 2014.
Clinical Repercussions
"Dementia: A Public Health Priority." WHO. World Health Organization and Alzheimer’s Disease International, 2012. Web. 10 Nov. 2014. <http://www.who.int/mental_health/publications/dementia_report_2012/en/>.
"Clinical Manifestations and Diagnostic Evaluation of Patients with Alzheimer's Disease"
Neurodegenerative Dementias. Clark, Christopher M.; Trojanowski, John Q.
"Stages of Alzheimer's." Alzinfo. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alzinfo.org/clinical-stages-of-alzheimers>.
"Everyday Life with Alzheimer's Disease." Bright Focus Foundation. N.p., n.d. Web. 19 Nov. 2011
<http://www.brightfocus.org/alzheimers/livingwith/everydaylife.html>.
"What Are the 7 Stages of Alzheimer’s Disease?" Alzheimers.net. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alzheimers.net/stages-of-alzheimers-disease/>.
"Seven Stages of Alzheimer's." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp>.
"Medications for Memory Loss." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_standard_prescriptions.asp>.
Treatments for Behavior." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_treatments_for_behavior.asp>.
"Clinical Manifestations and Diagnostic Evaluation of Patients with Alzheimer's Disease"
Neurodegenerative Dementias. Clark, Christopher M.; Trojanowski, John Q.
"Stages of Alzheimer's." Alzinfo. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alzinfo.org/clinical-stages-of-alzheimers>.
"Everyday Life with Alzheimer's Disease." Bright Focus Foundation. N.p., n.d. Web. 19 Nov. 2011
<http://www.brightfocus.org/alzheimers/livingwith/everydaylife.html>.
"What Are the 7 Stages of Alzheimer’s Disease?" Alzheimers.net. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alzheimers.net/stages-of-alzheimers-disease/>.
"Seven Stages of Alzheimer's." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp>.
"Medications for Memory Loss." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_standard_prescriptions.asp>.
Treatments for Behavior." Alz.org. N.p., n.d. Web. 19 Nov. 2014.
<http://www.alz.org/alzheimers_disease_treatments_for_behavior.asp>.
Research
"Can We Reverse Alzheimer's?" Harvard Health Publications. N.p., Jan. 2013. Web. 18 Nov. 2014.
<http://www.health.harvard.edu/newsletters/Harvard_Health_Letter/2013/January/can-we-reverse- alzheimers? utm_source=health&utm_medium=pressrelease&utm_campaign=health0113>.
"Developing New Treatments for Alzheimer's Disease." National Institute on Aging. N.p., 2012. Web. 18 Nov. 2014.
<http://www.nia.nih.gov/alzheimers/publication/2011-2012-alzheimers-disease-progress-report/developing-new-treatments>.
Mcnamee, David. "Potential New Alzheimer's Treatment May Come from an Unexpected Protein." Medical News Today. MediLexicon International, 23 May 2014. Web. 18 Nov. 2014. <http://www.medicalnewstoday.com/articles/277233.php>.
Ounallah-Saad, Hadile, Vijendra Sharma, Efrat Edry, and Kobi Rosenblum. "Genetic or Pharmacological Reduction of PERK Enhances Cortical- Dependent Taste Learning." Journal of Neuroscience (2014): 14624-4632. Web. 19 Nov. 2014. <http://www.jneurosci.org/content/34/44/14624.full.pdf+html>.
<http://www.health.harvard.edu/newsletters/Harvard_Health_Letter/2013/January/can-we-reverse- alzheimers? utm_source=health&utm_medium=pressrelease&utm_campaign=health0113>.
"Developing New Treatments for Alzheimer's Disease." National Institute on Aging. N.p., 2012. Web. 18 Nov. 2014.
<http://www.nia.nih.gov/alzheimers/publication/2011-2012-alzheimers-disease-progress-report/developing-new-treatments>.
Mcnamee, David. "Potential New Alzheimer's Treatment May Come from an Unexpected Protein." Medical News Today. MediLexicon International, 23 May 2014. Web. 18 Nov. 2014. <http://www.medicalnewstoday.com/articles/277233.php>.
Ounallah-Saad, Hadile, Vijendra Sharma, Efrat Edry, and Kobi Rosenblum. "Genetic or Pharmacological Reduction of PERK Enhances Cortical- Dependent Taste Learning." Journal of Neuroscience (2014): 14624-4632. Web. 19 Nov. 2014. <http://www.jneurosci.org/content/34/44/14624.full.pdf+html>.